-
Maternal hemodynamics in screen-positive and screen-negative women of the ASPRE trial.
Ling HZ, Guy GP, Bisquera A, Poon LC, Nicolaides KH, Kametas NA.
Ultrasound Obstet Gynecol 2019;54:51-57. pdf -
Maternal hemodynamics in normal pregnancy and in pregnancy affected by pre-eclampsia.
Stott D, Nzelu O, Nicolaides KH, Kametas NA.
Ultrasound Obstet Gynecol 2018;52:359-364. pdf -
Chronic hypertension and adverse pregnancy outcomes: a cohort study.
Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:228-235. pdf -
Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:203-9. pdf -
Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valino N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:194-202. pdf -
Inverted Pyramid of Care.
Sonek JD, Kagan KO, Nicolaides KH.
Clin Lab Med 2016;36:305-17. pdf -
Longitudinal changes in maternal hemodynamics in a population at risk for pre-eclampsia.
Khalil A, Garcia-Mandujano R, Maiz N, Elkhouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;44:197-204. pdf -
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.
Bujold E, Roberge S, Nicolaides KH.
Prenat Diagn 2014;34:642-8. pdf -
Clinical significance of first-trimester chorionic bumps: a matched case-control study.
Sana Y, Appiah A, Davison A, Nicolaides KH, Johns J, Ross JA.
Ultrasound Obstet Gynecol 2013;42:585-9. -
Maternal age and adverse pregnancy outcomes: a cohort study.
Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;42:634-43. pdf -
Maternal racial origin and adverse pregnancy outcome: a cohort study.
Khalil A, Rezende J, Akolekar R, Syngelaki A, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:278-85. -
Maternal hemodynamics at 11-13 weeks' gestation and the risk of preeclampsia.
Khalil A, Akolekar R, Syngelaki A, Elkhouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2012;40:28-34. -
Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, down's syndrome, preterm delivery and preeclampsia.
Chambers AE, Griffin C, Naif SA, Mills I, Mills WE, Syngelaki A, Nicolaides KH, Banerjee S.
Reprod Biol Endocrinol 2012;10:113. -
Body Mass Index at 11-13 Weeks' Gestation and Pregnancy Complications.
Syngelaki A, Bredaki FE, Vaikousi E, Maiz N, Nicolaides KH.
Fetal Diagn Ther 2011;30:250-65. -
Maternal arterial stiffness in women who subsequently develop pre-eclampsia.
Savvidou MD, Kaihura C, Anderson JM, Nicolaides KH.
PLoS One 2011;6:e18703. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Turning the pyramid of prenatal care.
Nicolaides KH.
Fetal Diagn Ther 2011;29:183-96. -
Maternal arterial stiffness in pregnancies affected by pre-eclampsia.
Kaihura C, Savvidou MD, Anderson JM, McEniery CM, Nicolaides KH.
Am J Physiol Heart Circ Physiol 2009;297:759-64. -
Effect of parity on maternal cardiac function during the first trimester of pregnancy.
Turan OM, De Paco C, Kametas N, Khaw A, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:849-54. -
Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:871-6.